Compounds in the library, AZD-01, have been designed to target GCPRs containing key amine recognition regions for both agonists and antagonists.

The Technologies will help to eliminate toxic compounds early in the drug discovery, extend the high image quality obtained in cellular assays and expand the possibilities for lead compound profiling and drug target validation.

ThemePair™ libraries of low molecular weight compounds bridge the gap between screening very small molecular weight ligands.

Under this program, software developers are collaborating with Affymetrix to deliver software solutions which apply gene expression and genetic variation data to translational medicine, discovery research and systems biology.

The CrystalQuick™Plus from Greiner Bio-One combines the optical properties of a flat crystallization well bottom with superior surface features.

The RT2Profiler™ PCR Array is a 96-well plate containing primers for a thoroughly researched panel of relevant, pathway or disease focused genes plus appropriate positive and negative controls.

MDS Sciex CellKey™ System allows for the measurement of endogenous cell surface receptor activation in live cells and generates data.

These solutions will provide quality advances in live cell screening and increase customers’ productivity and advance drug discovery research and results.

The technology provides insight into key mechanisms of embryonic stem cells and illnesses such as cancer, cardiovascular disease and central nervous system disorders.

The Finnigan LXQ Linear Ion Trap Mass Spectrometer advances high- throughput drug discovery and proteomics by making linear trap performance a cost-effective option for fast-paced analytical laboratories.